Regencell Bioscience Holdings financial statements
리젠셀 바이오사이언스 홀딩스NASDAQ:RGC · Nasdaq · Healthcare · sector #17$7.35+1.52%
2026-10-06 closeRegencell Bioscience Holdings's published financial data is dated 2026-10-04. 2025 revenue was $0M. 2025 operating profit was −$4M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy